Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Preclinical Research Department
Tali Voloshin has not added Biography.
If you are Tali Voloshin and would like to personalize this page please email our Author Liaison for assistance.
The angiogenic profile of colorectal cancer patients following open or laparoscopic colectomy.
Cancer biology & therapy Oct, 2010 | Pubmed ID: 20814248
G-CSF supplementation with chemotherapy can promote revascularization and subsequent tumor regrowth: prevention by a CXCR4 antagonist.
Blood Sep, 2011 | Pubmed ID: 21685373
Host response to short-term, single-agent chemotherapy induces matrix metalloproteinase-9 expression and accelerates metastasis in mice.
Cancer research Nov, 2011 | Pubmed ID: 21978934
Tumor-initiating cells of various tumor types exhibit differential angiogenic properties and react differently to antiangiogenic drugs.
Stem cells (Dayton, Ohio) Sep, 2012 | Pubmed ID: 22782858
The host immunological response to cancer therapy: An emerging concept in tumor biology.
Experimental cell research Jul, 2013 | Pubmed ID: 23518388
Lysyl oxidase-like-2 promotes tumour angiogenesis and is a potential therapeutic target in angiogenic tumours.
Carcinogenesis Oct, 2013 | Pubmed ID: 23828904
Differential therapeutic effects of anti-VEGF-A antibody in different tumor models: implications for choosing appropriate tumor models for drug testing.
Molecular cancer therapeutics Jan, 2014 | Pubmed ID: 24150126
Tumor-derived microparticles induce bone marrow-derived cell mobilization and tumor homing: a process regulated by osteopontin.
International journal of cancer Jul, 2014 | Pubmed ID: 24347266
Small but mighty: microparticles as mediators of tumor progression.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society Aug, 2014 | Pubmed ID: 24705797
Anti-Bv8 antibody and metronomic gemcitabine improve pancreatic adenocarcinoma treatment outcome following weekly gemcitabine therapy.
Neoplasia (New York, N.Y.) Jun, 2014 | Pubmed ID: 24957319
Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
Seminars in oncology Oct, 2014 | Pubmed ID: 25213867
Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion Molecules.
Molecular cancer therapeutics Jun, 2015 | Pubmed ID: 25852061
Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis.
Molecular cancer therapeutics Jun, 2015 | Pubmed ID: 25887886
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer Cells.
Scientific reports Dec, 2015 | Pubmed ID: 26658786
Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo.
International journal of cancer Dec, 2016 | Pubmed ID: 27561100
Novocure Ltd., Haifa, Israel
Yaara Porat1,
Moshe Giladi1,
Rosa S. Schneiderman1,
Roni Blat1,
Anna Shteingauz1,
Einav Zeevi1,
Mijal Munster1,
Tali Voloshin1,
Noa Kaynan1,
Orna Tal1,
Eilon D. Kirson2,
Uri Weinberg3,
Yoram Palti2
1Preclinical Research Department, Novocure Ltd., Haifa, Israel,
2, Novocure Ltd., Haifa, Israel,
3, Novocure GmbH, Lucerne, Switzerland
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.